查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
治療藥物監測市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測F 按產品、技術、藥物類別、終端用戶、地區和競爭情況分類
市場調查報告書
商品編碼
1309221

治療藥物監測市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測F 按產品、技術、藥物類別、終端用戶、地區和競爭情況分類

Therapeutic Drug Monitoring Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Product, By Technology, By Class of Drug, By End User, By Region, and Competition
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球治療藥物監測市場預計將在預測期內實現令人矚目的成長。全球醫療保健行業的擴張加速了對治療藥物監測的需求。治療藥物監測是一種檢測方法，通過測量血液中的幾種藥物來驗證給藥劑量是否正確。這種檢測通常是為了最佳化某些治療指數較窄的藥物的安全性和有效性，這意味著治療劑量和毒性劑量之間的差異相對較小。抗心律失常、抗生素、抗癲癇和精神藥物都需要進行監測，以保證其有效性和安全性。治療藥物監測的目的是確保患者接受正確劑量的藥物，以達到預期的治療效果，同時將不良反應的風險降至最低。它包括在特定時間間隔測量血液中的藥物濃度，並根據需要調整藥物劑量，以將藥物濃度維持在目標範圍內。隨著人們對藥物的準確劑量和治療效果的認知不斷提高，以及不同藥物的副作用和對患者健康的不良影響發生率的增加，預計未來幾年全球治療藥物監測市場將迎來有利可圖的發展機會。

研發和臨床試驗不斷成長

對治療藥物監測(TDM) 相關研發項目的日益關注以及藥物監測測試在不同治療領域的廣泛應用也對市場產生了影響。為擴大技術在不同適應症中的應用而不斷加大的研發力度和臨床研究，以及癌症、神經系統疾病、愛滋病、自身免疫性疾病和心臟病發病率的上升，都為全球治療藥物監測市場的成長提供了支持。臨床神經病學雜誌》於2021 年8 月報導，癲癇影響著全球7000 多萬人，是繼失智症和中風之後的第三大神經系統疾病。據世界衛生組織估計，截至2021 年，全球有超過5500 萬人患有失智症。每年報告的新病例將接近1 000 萬例。在60-70% 的病例中，最常見的失智症- 阿滋海默症可能是致病因素之一。因此，預計在預測期內，這些疾病風險的上升將推動治療藥物監測市場的擴大。

治療監控在器官移植中的應用

管理接受實體器官移植的患者需要對免疫抑製劑進行治療藥物監測。移植受者服用免疫抑製劑是為了防止機體對器官產生排斥反應。臨床醫生必須為每位患者量身定做免疫抑製劑藥物，以便在副作用的可能性和治療效果之間取得理想的平衡。由於患者的藥效學和藥代動力學各不相同，因此很難通過免疫抑製劑治療監測來實現這一目標。

精準用藥

近年來，精準醫療越來越受到關注，而治療藥物監測有望在這一方法中發揮重要作用。精準用藥是指根據患者的具體特徵，如遺傳、年齡、體重、器官功能和伴隨藥物等，為患者量身定製藥物劑量。治療藥物監測可幫助最佳化藥物劑量，實現個性化治療效果，從而在治療藥物監測實踐中更多地採用精準劑量方法。這反過來又將為預測期內全球治療藥物監測市場的成長開闢新的前景。

蓬勃發展的醫療保健IT 行業

擴大使用先進技術並將資訊技術融入醫療保健領域，使醫療保健行業發生了革命性變化。人工智慧（AI）和數據分析技術在醫療保健領域的應用呈上升趨勢，治療藥物監測也不例外。人工智慧算法和數據分析技術可用於分析藥物濃度數據、患者特徵和臨床結果等大型資料集，以確定模式和趨勢、最佳化用藥策略並改進治療藥物監測實踐，從而為全球治療藥物監測市場的成長創造了有利可圖的機會。

近年來，數位醫療技術和遠程醫療發展勢頭迅猛，治療藥物監測也被整合到這些平台中。智慧手機應用程式或穿戴式設備等數位健康工具可實現遠程監測藥物濃度，從而提供更方便、更容易獲得的治療藥物監測服務。遠程醫療還有助於根據治療藥物監測結果進行遠程會診和劑量調整，特別是在醫療服務有限的農村或偏遠地區，因此支持了全球治療藥物監測市場的成長。

最新進展

  • 2021 年1 月，Theradiag 宣布其用於生物療法監測的四種新型i-Tracker 檢測試劑盒獲得了CE 認證。
  • 2021 年11 月，Boditech Med 在MEDICA 2021 展會上發布了全新的一體化盒式系統和帶採血管的自動免疫分析儀。
  • 2022 年5 月，懷俄明州藥局和Bamboo Health（前身為Appriss Health 和PatientPing）於6 月29 日宣佈建立合作夥伴關係，為懷俄明州處方藥監控計劃（PDMP）提供解決方案。
  • 2022 年1 月，Seer 推出新一代蛋白質組學研究平台，可用於對人體內數以萬計的蛋白質進行分類，這些蛋白質驅動著生命和疾病的生物功能。
  • 2022 年3 月，Biognosys 推出其擴展的蛋白質組學平台套件，為客戶提供從早期發現到臨床設置的整個研發流程中的深入生物學見解。

可客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。報告可提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多五家）的詳細分析和概況。

目錄

第1 章：產品概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場
    • 研究年份
    • 主要市場細分

第2 章：研究方法

  • 研究目的
  • 基準方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第3 章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概述
  • 市場驅動因素、挑戰和趨勢概述

第4章：客戶之聲

第5章：全球治療藥物監測市場展望

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（耗材、設備、免疫分析儀、色譜與質譜檢測器、臨床化學分析儀）
    • 按技術（免疫測定、色譜-質譜法）
    • 按藥物類別（抗癲癇藥物、抗生素藥物、免疫抑製劑藥物、抗心律失常藥物、支氣管擴張藥物、精神活性藥物及其他）
    • 按最終用戶（醫院實驗室、商業和私人實驗室、其他）
    • 按地區
    • 按公司（2022 年）
  • 產品地圖
    • 按產品
    • 按技術分類
    • 按藥物類別
    • 按最終用戶
    • 按地區

第6 章：北美治療藥物監測市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（耗材、設備、免疫分析儀、色譜與質譜檢測器、臨床化學分析儀）
    • 按技術（免疫測定、色譜-質譜法）
    • 按藥物類別（抗癲癇藥物、抗生素藥物、免疫抑製劑藥物、抗心律失常藥物、支氣管擴張藥物、精神活性藥物及其他）
    • 按最終用戶（醫院實驗室、商業和私人實驗室及其他）
    • 按國家
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7 章：歐洲治療藥物監測市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（耗材、設備、免疫分析儀、色譜與質譜檢測器、臨床化學分析儀）
    • 按技術（免疫測定、色譜-質譜法）
    • 按藥物類別（抗癲癇藥物、抗生素藥物、免疫抑製劑藥物、抗心律失常藥物、支氣管擴張藥物、精神活性藥物及其他）
    • 按最終用戶（醫院實驗室、商業和私人實驗室及其他）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 英國
    • 義大利
    • 德國
    • 西班牙

第8 章: 亞太地區治療藥物監測市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（耗材、設備、免疫分析儀、色譜與質譜檢測器、臨床化學分析儀）
    • 按技術（免疫測定、色譜-質譜法）
    • 按藥物類別（抗癲癇藥物、抗生素藥物、免疫抑製劑藥物、抗心律失常藥物、支氣管擴張藥物、精神活性藥物及其他）
    • 按最終用戶（醫院實驗室、商業和私人實驗室及其他）
    • 按國家
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第9 章: 南美治療藥物監測市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（耗材、設備、免疫分析儀、色譜與質譜檢測器、臨床化學分析儀）
    • 按技術（免疫測定、色譜-質譜法）
    • 按藥物類別（抗癲癇藥物、抗生素藥物、免疫抑製劑藥物、抗心律失常藥物、支氣管擴張藥物、精神活性藥物及其他）
    • 按最終用戶（醫院實驗室、商業和私人實驗室及其他）
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10 章：中東和非洲治療藥物監測市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（耗材、設備、免疫分析儀、色譜與質譜檢測器、臨床化學分析儀）
    • 按技術（免疫測定、色譜-質譜法）
    • 按藥物類別（抗癲癇藥物、抗生素藥物、免疫抑製劑藥物、抗心律失常藥物、支氣管擴張藥物、精神活性藥物及其他）
    • 按最終用戶（醫院實驗室、商業和私人實驗室及其他）
    • 按國家
  • 中東和非洲：國家分析
    • 南非治療藥物監測
    • 阿拉伯聯合大公國治療藥物監測
    • 沙烏地阿拉伯治療藥物監測
    • 土耳其治療藥物監測
    • 埃及治療藥物監測

第11 章：市場動態

  • 驅動因素
  • 挑戰

第12 章：市場趨勢與發展

  • 產品發布
  • 合併與收購
  • 技術進步

第13 章：全球治療藥物監測市場：SWOT 分析

第14章：競爭格局

  • 羅氏公司
    • Business Overview
    • Product Offerings
    • Recent Developments
    • Financials (In Case of Listed Companies)
    • Key Personnel
    • SWOT Analysis
  • 西門子醫療保健有限公司
  • 賽默飛世爾科技公司
  • Bio-Rad Laboratories, Inc.
  • 貝克曼庫爾特公司
  • 雅培實驗室公司
  • 安捷倫科技公司
  • 生物梅里埃公司
  • Alere, Inc.

第15 章：戰略建議

簡介目錄
Product Code: 5028

Global Therapeutic Drug Monitoring Market is projected to witness impressive growth during the forecast period. The worldwide healthcare industry's expansion is accelerating the demand for therapeutic medication monitoring. Therapeutic drug monitoring is a test that measures several medications in the bloodstream to verify the correct dosage of medication being given. This is typically done to optimize the safety and effectiveness of certain medications that have a narrow therapeutic index, meaning that the difference between a therapeutic dose and a toxic dose is relatively small. Anti-arrhythmic, antibiotic, anti-epileptic, and psychotropic medications all require monitoring to guarantee their effectiveness and safety. The goal of therapeutic drug monitoring is to ensure that a patient is receiving the right dose of medication to achieve the desired therapeutic effect while minimizing the risk of adverse effects. It involves measuring drug concentrations in the blood at specific intervals and adjusting the medication dosage as needed to maintain drug levels within the target range. The growing awareness among the population pertaining to accurate dosage, and therapeutic effects of drugs coupled with increased incidences of side-effects and adverse impacts on patient health due to different medications is expected to create lucrative opportunities for the growth of global therapeutic drug monitoring market in the next few years.

The rise in demand for hospitals and medical care institutions across the globe acts as one of the major factors driving the growth of therapeutic drug monitoring market. The growing inclination for precision medicine and the significance of therapeutic drug monitoring (TDM) in organ transplant procedures both speed up market expansion. The therapeutic drug monitoring market is also positively impacted by changes in the medical sector, rising awareness, technical advancements, and a surge in pharmaceutical company investment. Additionally, the market players would benefit from increased use in the treatment of autoimmune illnesses during the projected period 2024 to 2028.

Additionally, the growing use of therapeutic drug monitoring across biologics industry and in point of care testing is further expected to support the global therapeutic drug monitoring market growth in the next few years. Biologic drugs, which are large complex molecules used to treat various conditions such as cancer, autoimmune diseases, and inflammatory disorders, are becoming increasingly important in clinical practice. Therapeutic Drug Monitoring for biologics, such as monoclonal antibodies, may involve measuring drug concentrations and anti-drug antibody levels to optimize dosing, assess treatment response, and manage immunogenicity. Similarly, Point-of-care testing (POCT), which involves performing diagnostic tests near the patient rather than sending samples to a central laboratory, is gaining popularity in clinical practice. POCT for Therapeutic Drug Monitoring may allow for more rapid and convenient monitoring of drug concentrations, enabling quicker dose adjustments and improving patient care, especially in critical care settings or resource-limited environments.

Growing Research and Development Along with Clinical Trials

The market is also influenced by the increased attention being paid to research and development projects relating to therapeutic drug monitoring (TDM) and the widespread use of the drug monitoring test in different therapeutic sectors. Increasing R&D efforts and clinical studies to broaden the use of technology in diverse indications, as well as rising rates of cancer, neurological disorders, HIV, autoimmune, and cardiac ailments, are supporting the growth of global therapeutic drug monitoring market. The Journal of Clinical Neurology reported in August 2021 that epilepsy, which affects over 70 million people globally, is the third most prevalent neurological condition after dementia and stroke. More than 55 million people are living with dementia worldwide as of 2021, estimates the WHO. Every year, there would be close to 10 million new cases reported. The most prevalent form of dementia, Alzheimer's disease, may be a factor in 60-70% of cases. Therefore, it is predicted that over the course of the projection period, rising risks of these diseases is anticipated to fuel Therapeutic Drug Monitoring market expansion.

Use of Therapeutic Monitoring in Organ Transplant

Managing patients receiving solid-organ transplants requires conducting therapeutic drug monitoring for immunosuppressive medicines. Immunosuppressants are given to transplant recipients in order to prevent organ rejection by the body. Clinicians must tailor the immunosuppressant medication they give to each patient in order to strike the ideal balance between the likelihood of side effects and the efficacy of treatment. It can be tough to accomplish this goal with immunosuppressant therapy monitoring since patients have varied pharmacodynamics and pharmacokinetics.

Precision Dosing

Precision medicine has gained increasing attention in recent years, and Therapeutic Drug Monitoring is expected to play a significant role in this approach. Precision dosing involves tailoring drug dosages to individual patients based on their specific characteristics, such as genetics, age, weight, organ function, and concomitant medications. Therapeutic Drug Monitoring can help optimize drug dosing to achieve personalized therapeutic outcomes, and hence lead to more adoption of precision dosing approaches in Therapeutic Drug Monitoring practice. This, in turn, will open new prospects for the growth of global therapeutic drug monitoring market in the forecast period.

Flourishing Healthcare IT Industry

The increasing use of advanced technologies and integration of IT into healthcare has revolutionized the healthcare industry. The use of artificial intelligence (AI) and data analytics in healthcare is on the rise, and Therapeutic Drug Monitoring is no exception. AI algorithms and data analytics techniques can be used to analyze large datasets of drug concentration data, patient characteristics, and clinical outcomes to identify patterns and trends, optimize dosing strategies, and improve Therapeutic Drug Monitoring practices, thereby creating lucrative opportunities for the growth of global therapeutic drug monitoring market.

Digital health technologies and telemedicine have gained momentum in recent years, and Therapeutic Drug Monitoring is also being integrated into these platforms. Digital health tools, such as smartphone apps or wearable devices, can enable remote monitoring of drug concentrations, allowing for more convenient and accessible Therapeutic Drug Monitoring services. Telemedicine can also facilitate remote consultations and dose adjustments based on Therapeutic Drug Monitoring results, particularly in rural or remote areas where access to healthcare may be limited, hence, supporting the growth of global therapeutic drug monitoring market.

Market Segmentation

Global Therapeutic Drug Monitoring Market is segmented based on product, technology, class of drug, end user, and region. By product, global therapeutic drug monitoring market can be segmented into consumables, equipment, immunoassay analyzers, chromatography & MS detectors, and clinical chemistry analyzers. By technology, global therapeutic drug monitoring market can be categorized into immunoassays and chromatography-mass spectrometry. Immunoassays can be further sub-segmented into Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, and Others. Chromatography-Mass Spectrometry can be split into LC-MS and GC-MS. By Class of Drug, global therapeutic drug monitoring market can be fragmented into Antiepileptic Drugs, Antibiotic Drug, Immunosuppressant Drugs, Antiarrhythmic Drug, Bronchodilator Drugs, Psychoactive Drugs, and Others. In terms of end users, global therapeutic drug monitoring market can be divided into Hospital Labs, Commercial & Private Lab, and Others. Regionally, global therapeutic drug monitoring market can be categorized into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Recent Developments

  • In January 2021, Theradiag announced that it had received CE marking for four new i-Tracker test kits for biotherapy monitoring.
  • In November 2021, Boditech Med unveiled their brand-new all-in-one cartridge system and automated immunoassay analyzer with a blood collection tube at the MEDICA 2021 trade fair.
  • The Wyoming Board of Pharmacy and Bamboo Health, formerly Appriss Health and PatientPing, announced a partnership on June 29 in May 2022, to create a solution for the Wyoming Prescription Drug Monitoring Program (PDMP).
  • In January 2022, Seer launched a next-generation proteomics research platform that can be used for categorizing the tens of thousands of proteins within the human body that drive the biological functions of both life and disease.
  • In March 2022, Biognosys launched its expanded suite of proteomics platforms which provides its customers with deep biological insights across the entire R&D pipeline, from early-stage discovery to clinical settings.

Market players

Roche AG, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMerieux, Inc., Alere, Inc, among others, are some of the key players operating in the global therapeutic drug monitoring market.

Report Scope:

In this report, the Global Therapeutic Drug Monitoring Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Global Therapeutic Drug Monitoring Market, By Product:

  • Consumables
  • Equipment
  • Immunoassay Analyzers
  • Chromatography & MS Detector
  • Clinical Chemistry Analyzers

Global Therapeutic Drug Monitoring Market, By Technology:

  • Immunoassay
    • Chemiluminescence Immunoassay
    • Colorimetric Immunoassay
    • Fluorescence
    • Immunoassay
    • Radioimmunoassay
    • Others
  • Chromatography-Mass Spectrometry
    • LC-MS
    • GC-MS

Global Therapeutic Drug Monitoring Market, By Class of Drug:

  • Antiepileptic Drug
  • Antibiotic Drug
  • Immunosuppressant Drug
  • Antiarrhythmic Drug
  • Bronchodilator Drug
  • Psychoactive Drug
  • Others

Global Therapeutic Drug Monitoring Market, By Class of Drug:

  • Hospital Labs
  • Commercial & Private Labs
  • Others

Global Therapeutic Drug Monitoring Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • South Arabia
    • Saudi Africa
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Drug Monitoring Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Therapeutic Drug Monitoring Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 5.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 5.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 5.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 5.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 5.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Product
    • 5.3.2. By Technology
    • 5.3.3. By Class of Drug
    • 5.3.4. By End User
    • 5.3.5. By Region

6. North America Therapeutic Drug Monitoring Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 6.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 6.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 6.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 6.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 6.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Therapeutic Drug Monitoring Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Class of Drug
        • 6.3.1.2.4. By End- User
    • 6.3.2. Canada Therapeutic Drug Monitoring Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Class of Drug
        • 6.3.2.2.4. By End- User
    • 6.3.3. Mexico Therapeutic Drug Monitoring Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Class of Drug
        • 6.3.3.2.4. By End- User

7. Europe Therapeutic Drug Monitoring Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 7.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 7.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 7.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 7.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 7.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Therapeutic Drug Monitoring Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Class of Drug
        • 7.3.1.2.4. By End- User
    • 7.3.2. United Kingdom Therapeutic Drug Monitoring Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Class of Drug
        • 7.3.2.2.4. By End- User
    • 7.3.3. Italy Therapeutic Drug Monitoring Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Class of Drug
        • 7.3.3.2.4. By End- User
    • 7.3.4. Germany Therapeutic Drug Monitoring Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Class of Drug
        • 7.3.4.2.4. By End- User
    • 7.3.5. Spain Therapeutic Drug Monitoring Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Class of Drug
        • 7.3.5.2.4. By End- User

8. Asia-Pacific Therapeutic Drug Monitoring Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 8.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 8.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 8.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 8.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 8.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Therapeutic Drug Monitoring Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Class of Drug
        • 8.3.1.2.4. By End- User
    • 8.3.2. India Therapeutic Drug Monitoring Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Class of Drug
        • 8.3.2.2.4. By End- User
    • 8.3.3. Japan Therapeutic Drug Monitoring Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Class of Drug
        • 8.3.3.2.4. By End- User
    • 8.3.4. South Korea Therapeutic Drug Monitoring Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Class of Drug
        • 8.3.4.2.4. By End- User
    • 8.3.5. Australia Therapeutic Drug Monitoring Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Class of Drug
        • 8.3.5.2.4. By End- User

9. South America Therapeutic Drug Monitoring Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 9.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 9.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 9.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 9.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 9.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Therapeutic Drug Monitoring Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Class of Drug
        • 9.3.1.2.4. By End- User
    • 9.3.2. Argentina Therapeutic Drug Monitoring Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Class of Drug
        • 9.3.2.2.4. By End- User
    • 9.3.3. Colombia Therapeutic Drug Monitoring Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Class of Drug
        • 9.3.3.2.4. By End- User

10. Middle East and Africa Therapeutic Drug Monitoring Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 10.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 10.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 10.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 10.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 10.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Therapeutic Drug Monitoring Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Class of Drug
        • 10.3.1.2.4. By End- User
    • 10.3.2. UAE Therapeutic Drug Monitoring Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Class of Drug
        • 10.3.2.2.4. By End- User
    • 10.3.3. Saudi Arabia Therapeutic Drug Monitoring Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Class of Drug
        • 10.3.3.2.4. By End- User
    • 10.3.4. Turkey Therapeutic Drug Monitoring Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Technology
        • 10.3.4.2.3. By Class of Drug
        • 10.3.4.2.4. By End- User
    • 10.3.5. Egypt Therapeutic Drug Monitoring Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product
        • 10.3.5.2.2. By Technology
        • 10.3.5.2.3. By Class of Drug
        • 10.3.5.2.4. By End- User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Global Therapeutic Drug Monitoring Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Roche AG
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (In Case of Listed Companies)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Siemens Healthcare GmbH
  • 14.3. Thermo Fisher Scientific, Inc.
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Beckman Coulter, Inc.
  • 14.6. Abbott Laboratories, Inc.
  • 14.7. Agilent Technologies, Inc.
  • 14.8. bioMerieux, Inc.
  • 14.9. Alere, Inc.

15. Strategic Recommendations